The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
Authors
Keywords
-
Journal
BMC CANCER
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2012-03-23
DOI
10.1186/1471-2407-12-107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastrointestinal Stromal Tumors
- (2012) Piotr Rutkowski et al. Molecular Diagnosis & Therapy
- Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
- (2011) Petri Bono et al. ACTA ONCOLOGICA
- Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib
- (2011) O. Dudeck et al. ANNALS OF ONCOLOGY
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib
- (2010) Astrid A.M. van der Veldt et al. ANTI-CANCER DRUGS
- Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance
- (2010) J. P. DiNitto et al. JOURNAL OF BIOCHEMISTRY
- Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors
- (2010) Susan A. J. Vaziri et al. Current Oncology Reports
- Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor
- (2009) B. I. Levy ANNALS OF ONCOLOGY
- Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib
- (2009) J.-Y. Blay ANNALS OF ONCOLOGY
- Arterial hypertension and clinical benefit of sunitinib, sorafenib and bevacizumab in first and second-line treatment of metastatic renal cell cancer
- (2009) A. Ravaud et al. ANNALS OF ONCOLOGY
- The Role of Vascular Endothelial Growth Factor Genetic Variability in Cancer
- (2009) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Mechanisms of Sunitinib Resistance in Gastrointestinal Stromal Tumors Harboring KITAY502-3ins Mutation: An In vitro Mutagenesis Screen for Drug Resistance
- (2009) T. Guo et al. CLINICAL CANCER RESEARCH
- Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
- (2009) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene
- (2009) Toshirou Nishida et al. International Journal of Clinical Oncology
- Emergency surgery in the era of molecular treatment of solid tumours
- (2009) Piotr Rutkowski et al. LANCET ONCOLOGY
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
- (2009) L. Jain et al. MOLECULAR CANCER THERAPEUTICS
- KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients
- (2009) K. S. Gajiwala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis
- (2008) Xiaolei Zhu et al. ACTA ONCOLOGICA
- The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation
- (2008) P Wolter et al. BRITISH JOURNAL OF CANCER
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
- (2008) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
- (2008) Michael C. Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started